A great deal has been written about Merck’s drug Fosamax and its health and safety problems. As previously reported, there have been a number of Fosamax-related cases filed around the country. The first Fosamax trial is scheduled in federal court in New York City for August 2009. This will be the first of three bellwether cases tried in the MDL. Lawyers in our firm are working on several Fosamax cases as well, including one set for trial in Montgomery, Alabama, in the fall of 2009. Fosamax users around the country have suffered significant injuries, including osteonecrosis of the jaw, as a result of using Fosamax. Osteonecrosis of the jaw, or “ONJ,” is a disfiguring and disabling condition of the jaw bone which includes severe infection and rotting of the jaw bone. If you have questions about Fosamax, you can contact Chad Cook (Chad.Cook@BeasleyAllen.com) at our firm at 800-898-2034.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.